Pharmacological evidence for curcumin neuroprotective effects against lead-stimulated neurodegeneration: possible role of Akt/GSK3 signaling pathway

Document Type : Research article

Authors

1 Department of Veterinary and Biomedical Science University of Minnesota, USA.

2 Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

3 Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

4 Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.

5 Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.

6 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

7 Department of Animal science, Qaemshahr Branch, Islamic Azad University, Mazandaran, Iran

Abstract

One of the main herbal compounds with neuroprotective effects is curcumin. Lead poisoning cause neurodegeneration effect, however, its mechanism is unclear. The present study assesses the role of Akt/GSK3 signaling pathway in mediating the neuroprotective actions of curcumin against lead-stimulated neurodegeneration. Sixty, adult male, rats were divided in to: Group 1 and 2 received normal saline and drinking water containing 0.075% of lead acetate. Groups 3, 4, 5 and 6 were treated simultaneously with lead acetate (0.075% in drinking water) and I.P. injection of curcumin (10, 20, 40 and 60 mg/kg).Morris water maze (MWM) was used to estimate cognitive activity, Hippocampal oxidative, anti-oxidant, inflammatory and apoptotic factors and also protein kinase B (Akt) and glycogen synthase kinase 3(GSK3) protein levels were studied. We found that lead poisoning disturbed the learning and memory and simultaneous treatment with curcumin reduced the lead -stimulated cognition disorders. Furthermore, treatment with lead acetate triggered an increase in lipid peroxidation and levels of interleukin 1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), oxidized form of glutathione (GSSG), Bax, GSK3 (total and phosphorylated) while decreasing the reduced form of glutathione (GSH), Bcl-2, and Akt3 (total and phosphorylated) in the hippocampus. Lead also decreased the action of superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione reductase (GR) in the hippocampus. Conversely, several doses of curcumin attenuated lead-stimulated apoptosis, oxidative stress, and inflammation; whereas increasing Akt (both forms) and reducing GSK3 (both forms) levels. Consequently, curcumin through the mediation of Akt/GSK3 signaling pathway promotes neuroprotection against lead-stimulated neurodegeneration.

Graphical Abstract

Pharmacological evidence for curcumin neuroprotective effects against lead-stimulated neurodegeneration: possible role of Akt/GSK3 signaling pathway

Keywords


  • . Needleman H and Lead poisoning. Rev. Med. (2004) 55: 209-22.
  • . Gurer H and Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol. Med. (2000) 29: 927-45.
  • . Byers RK and Lord EE. Late effects of lead poisoning on mental development.   J. Dis. Child. (1943) 66: 471-94.
  • . Toscano CD and Guilarte TR. Lead neurotoxicity: from exposure to molecular effects. Brain Res. Rev. (2005) 49: 529-54.
  • Patrick L. Lead Toxicity, a review of the literature. Part I: Exposure, Evaluation, and treatment. Altern Med. Rev. (2006) 11: 21-22.
  • Papanikolaou NC, Hatzidaki EG, Belivanis S, Tzanakakis GN and Tsatsakis AM. Lead toxicity update. A brief review. Sci. Monit. Basic Res. (2005) 11: RA329-RA36.
  • . Ahamed M and Siddiqui M. Low level lead exposure and oxidative stress: current opinions. Chimica. Acta. (2007) 383: 57-64.
  • . Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield, RL,Dietrich N, Bornschein R and Greene T.Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis.  Health Perspect. (2005) 113: 894-899.
  • . Li X, Long Y, Fang X and Liu X. Effect of vitamin C and E on antioxidative enzyme, NOS activity and NO contents in hippocampus of rats with lead poisoning.  Zhejiang Univ. Sci. (2008) 37: 189-92.
  • Jiang Y-M, Long L-L, Zhu X-Y, Zheng H, Fu X, Ou S-Y, Dong LV, Hai LZ and Wey Z. Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: A study by magnetic resonance imaging and 1H magnetic resonance spectroscopy. Lett. (2008) 181: 118-25.
  • Sharifi AM, Mousavi SH and Jorjani M. Effect of chronic lead exposure on pro-apoptotic Bax and anti-apoptotic Bcl-2 protein expression in rat hippocampus in-vivo. Cmnedi. (2010) 30: 769-74.
  • Nava-Ruiz C, Méndez-Armenta M and Ríos C. Lead neurotoxicity: effects on brain nitric oxide synthase. Mol. Histol. (2012) 43: 553-63.
  • Raza H, John A, Brown EM, Benedict S and Kambal A. Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells. Appl. Pharmacol. (2008) 226: 161-8.
  • Zbarsky V, Datla KP, Parkar S,Rai DK, Aruoma OI and Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. (2005) 39: 1119-25.
  • Cole GM, Teter B and Frautschy SA. Neuroprotective effects of curcumin. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease: Springer (2007) 197-212.
  • Kuhad A, Pilkhwal S, Sharma S, Tirkey N and Chopra K. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. Agric. Food Chem. (2007) 55: 10150-5.
  • Tiwari V and Chopra K. Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol. Psychopharmacol. (2012) 224: 519-35.
  • Chen G, Bower KA, Ma C, Fang S, Thiele CJ and Luo J. Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death. FASEB J. (2004) 18: 1162-4.
  • Endo H, Nito C, Kamada H, Yu F and Chan PH. Akt/GSK3β survival signaling is involved in acute brain injury after subarachnoid hemorrhage in rats. Stroke (2006) 37: 2140-6.
  • Beaulieu J-M, Gainetdinov RR and Caron MG. Akt/GSK3 signaling in the action of psychotropic drugs. Annu. (2009): 327-47.
  • . Kitagishi Y, Kobayashi M, Kikuta K and Matsuda S. Roles of PI3K/AKT/GSK3/mTOR pathway in cell signaling of mental illnesses. Depress Res. Treat. (2012) 2012: 272563.
  • D’Hooge R and  De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res. Rev. (2001) 36: 60-90.
  • Motaghinejad M, Motevalian M, Larijani SF and Khajehamedi Z. Protective effects of forced exercise against methylphenidate-induced anxiety, depression and cognition impairment in rat. Biomed. Res. (2015) 4:134
  • Motaghinejad M, Fatima S, Karimian M and Ganji S. Protective effects of forced exercise against nicotine-induced anxiety, depression and cognition impairment in rat. Basic Clin. Physiol. Pharmacol. (2015) 27: 19-26.
  • Vorhees CV and Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Protoc. (2006) 1: 848-58.
  • Bromley-Brits K, Deng Y and Song W. Morris water maze test for learning and memory deficits in Alzheimer's disease model mice. Vis. (2011) 53: 2920
  • Motaghinejad M, Motevalian M and Shabab B. Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats. Lett. (2016) 619: 106-13
  • Motaghinejad M, Karimian SM, Motaghinejad O, Shabab B, Asadighaleni M and Fatima S. The effect of various morphine weaning regimens on the sequelae of opioid tolerance involving physical dependency, anxiety and hippocampus cell neurodegeneration in rats. Fundam Clin. Pharmacol. (2015) 29: 299-309.
  • Perier C, Tieu K, Guégan C, Caspersen C, Jackson-Lewis V, Carelli V, Martinuzzi A,Hirano M, Przedborski S and Vila M.Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proceedings of the PNAS. (2005) 102: 19126-31.
  • Dong F, Zhang X, Culver B, Chew HG, Kelley RO and Ren J. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Sci. (2005) 109: 277-86.
  • Motaghinejad M, Motevalian M and Shabab B. Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats. Lett. (2016) 619: 106-13.
  • Garcia YJ, Rodríguez-Malaver AJ and Peñaloza N. Lipid peroxidation measurement by thiobarbituric acid assay in rat cerebellar slices. Neurosci. Methods (2005) 144: 127-35.
  • Motaghinejad M and Motevalian M. Involvement of AMPA/kainate and GABA A receptors in topiramate neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and inflammation in rat isolated hippocampus. J. Pharmacol. (2016) 784: 181-91.
  • Weydert CJ and Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Protoc. (2010) 5: 51-66.
  • Yannarelli GG, Fernández-Alvarez AJ, Santa-Cruz DM and Tomaro ML. Glutathione reductase activity and isoforms in leaves and roots of wheat plants subjected to cadmium stress. Phytochemistry (2007) 68:505-12.
  • Arican O, Aral M, Sasmaz S and Ciragil P. Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. (2005) 2005: 273-9.
  • Demircan N, Safran B, Soylu M, Ozcan A and Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (2006) 20: 1366-9.
  • Shi Y-Q, Huang T-W, Chen L-M, Pan X-D, Zhang J, Zhu Y-G and Chen, X-C. Ginsenoside Rg1 attenuates amyloid-β content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice. Alzheimers. Dis. (2010) 19: 977-89.
  • Lee B-H, Kim H, Park S-H and Kim Y-K. Decreased plasma BDNF level in depressive patients. Affect. Disord. (2007) 101: 239-44.
  • Weuve J, Press DZ, Grodstein F, Wright RO, Hu H and Weisskopf MG. Cumulative exposure to lead and cognition in persons with Parkinson's disease. Disorders. (2013) 28: 176-82.
  • Chen J, Zhu W, Chen Q, and Lü L. Effects of lead on the Brn-3a expression and the apoptosis in hippocampus neurons. Sheng Yan Jiu. (2004) 33: 134-6
  • Cox KH, Pipingas A and Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. Psychopharmacol. (2015) 29: 642-51.
  • Wu A, Ying Z and Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Neurol. (2006) 197: 309-17.
  • Motaghinejad M, Motevalian M, Fatima S, Hashemi H and Gholami M. Curcumin confers neuroprotection against alcohol-induced hippocampal neurodegeneration via CREB-BDNF pathway in rats. Pharmacother. (2017) 87: 721-40.
  • Motaghinejad M, Motevalian M, Fatima S, Faraji F and Mozaffari S. The Neuroprotective Effect of Curcumin Against Nicotine-Induced Neurotoxicity is Mediated by CREB–BDNF Signaling Pathway. Res. (2017) 42: 2921-32.
  • Kasperczyk S, Kasperczyk A, Ostałwska A, Dziwisz M and Birkner E. Activity of glutathione peroxidase, glutathione reductase, and lipid peroxidation in erythrocytes in workers exposed to lead. Trace. Elem. Res. (2004) 102: 61-68.
  • Mudipalli A. Lead hepatotoxicity & potential health effects. Indian J. Med. Res. (2007) 126: 518-525.
  • Verma S and Dubey R. Lead toxicity induces lipid peroxidation and alters the activities of antioxidant enzymes in growing rice plants. Plant Sci. (2003) 164: 645-55.
  • Carocci A, Catalano A, Lauria G, Sinicropi MS and Genchi G. Lead toxicity, antioxidant defense and environment. Reviews of Environmental Contamination and Toxicology Volume 238, Springer (2016) 45-67. 
  • Zhao J, Zhao Y, Zheng W, Lu Y, Feng G and Yu S. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Res. (2008) 1229: 224-32.
  • Biswas SK, McClure D, Jimenez LA, Megson IL and Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Redox. Signal. (2005) 7: 32-41.
  • Nishinaka T, Ichijo Y, Ito M, Kimura M, Katsuyama M, Iwata K, Miura T, Terada T and Yabe-Nishimura C. Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element. Lett. (2007) 170:238-47.
  • Vaziri ND, Lin C-Y, Farmand F and Sindhu RK. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension. Kidney Int. (2003) 63:186-94.
  • Bayrak O, Uz E, Bayrak R, Turgut F, Atmaca AF, Sahin S, Yıldırım ME, Kaya A, Cimentepe E and Akcay A. Curcumin protects against ischemia/reperfusion injury in rat kidneys. World J. Urol. (2008) 26: 285-91.
  • Patrick L. Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Med. Rev. (2006) 11: 114-121.
  • Sharifi AM, Baniasadi S, Jorjani M, Rahimi F and Bakhshayesh M. Investigation of acute lead poisoning on apoptosis in rat hippocampus in-vivo. Lett. (2002) 329: 45-8.
  • Wang Q, Sun AY, Simonyi A, Jensen MD, Shelat PB, Rottinghaus GE, MacDonald R-S, Miller DK,Lubahn DE and Weisman GA. Neuroprotective mechanisms of curcumin against cerebral ischemia‐induced neuronal apoptosis and behavioral deficits. Neurosci. Res. (2005) 82: 138-48.
  • Zhang G, Zhang T, Li N, Wu L, Gu J, Li C, Zhao C, Liu, W, Shan Land YP. Tetramethylpyrazine nitrone activates the BDNF/Akt/CREB pathway to promote post-ischaemic neuroregeneration and recovery of neurological functions in rats. J. Pharmacol. (2018) 175: 517-31.
  • .Kaytor MD and Orr HT. The GSK3β signaling cascade and neurodegenerative disease. Opin. Neurol. (2002) 12: 275-8.
  • Mayr B and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. N Rev. Mol. Cell Biol. (2001) 2: 599-609.
  • Zhang X, Yin W-k, Shi X-d and Li Y. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells. J. Pharm. Sci. (2011) 42: 540-6.
  • Huang H-C, Xu K and Jiang Z-F. Curcumin-mediated neuroprotection against amyloid-β-induced mitochondrial dysfunction involves the inhibition of GSK-3β. Alzheimers. Dis. (2012) 32: 981-96.